Treatment of venous malformations: First experience with a new sclerosing agent – A multicenter study-Reference-Cited by-同舟云学术

Treatment of venous malformations: First experience with a new sclerosing agent – A multicenter study

Published:2011-12 Issue:3 Volume:80 Page:e366-e372
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Schumacher Martin,Dupuy Patrick,Bartoli Jean-Michel,Ernemann Ulrike,Herbreteau Denis,Ghienne Corinne,Guibaud Laurent,Loose Dirk A.,Mattassi Raul,Petit Philippe,Rössler Jochen K.,Stillo Francesco,Weber Johannes

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference20 articles.

1. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification;Goyal;Radiology,2002

2. Venous malformations in the face and neck radiologic diagnosis and treatment with absolute ethanol;Berthelsen;Acta Radiol Diagn (Stockh),1986

3. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results;Lee;J Vasc Surg,2003

4. Ethanol sclerotherapy of peripheral venous malformations;Rimon;Eur J Radiol,2004

5. Treatment of venous malformations by direct injection with ethanol;Shireman;J Vasc Surg,1997

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments;Annual Review of Genomics and Human Genetics;2024-08-27

2. Designs used in published therapeutic studies of rare superficial vascular anomalies: a systematic literature search;BMC Medical Research Methodology;2023-08-30

3. Multicentered analysis of percutaneous sclerotherapies in venous malformations of the face;Frontiers in Medicine;2022-12-13

4. Malformations veineuses du pied : une étude épidémiologique descriptive;Médecine et Chirurgie du Pied;2022-03

5. Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model;PLOS ONE;2021-01-28